HSBC Holdings’s NxStage Medical Inc. NXTM Stock Holding History

HSBC Holdings’s Portfolio NXTM Stock Details NXTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-89,923	Closed	-$2.57M	–	2978
2018 Q4	$2.57M	Buy	+89,923	New	+$2.55M	﹤0.01%	1393
2018 Q3	–	Sell	-126,803	Closed	-$3.54M	–	2736
2018 Q2	$3.54M	Sell	126,803 -94,466	-43%	-$2.53M	0.01%	1286
2018 Q1	$5.5M	Sell	221,269 -33,458	-13%	-$814K	0.01%	1076
2017 Q4	$6.17M	Buy	+254,727	New	+$6.71M	0.01%	803
2017 Q1	–	Sell	-14,208	Closed	-$372K	–	2789
2016 Q4	$372K	Buy	+14,208	New	+$351K	﹤0.01%	2062

Other funds holding NXTM

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

HSBC Holdings's NXTM Position: Q1 2019 in Review

HSBC Holdings sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 89,923 shares — an estimated $2.57M sold.

HSBC Holdings first reported a position in NXTM in Q4 2016 and held it in 5 quarters. The position peaked at $6.17M in Q4 2017. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.

HSBC Holdings reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
HSBC Holdings sold 89,923 NxStage Medical Inc. shares in Q1 2019, an estimated $2.57M.
HSBC Holdings first reported a position in NxStage Medical Inc. in Q4 2016 and held it in 5 quarters.
HSBC Holdings's NxStage Medical Inc. position peaked at $6.17M in Q4 2017.
1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.

Based on HSBC Holdings's 13F filing for Q1 2019, filed 15 May 2019.